Author

Felicia Hansen

Queensland University of Technology

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:metabolomics· 1

Frequent Co-Authors

Amy Nguyen· 1 shared Berwyck L. J. PoadiD· 1 shared Eileen Ding· 1 shared J. Lising· 1 shared Jan Philipp MenzeliD· 1 shared Konstantina Harellis· 1 shared Laura L. Y. Choong· 1 shared Linda L. GarthwaiteiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Amy Nguyen

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Targeting de novo lipogenesis improves gemcitabine efficacy in pancreatic ductal adenocarcinoma

Sarah E. Hancock, Linda L. Garthwaite, Konstantina Harellis, Michael Susetio, Eileen Ding, Laura L. Y. Choong, Osvaldo Contreras, Amy Nguyen, J. Lising, Felicia Hansen, Puttandon Wongsomboon, Jan Philipp Menzel, Berwyck L. J. Poad, Todd W. Mitchell, Stephen J. Blanksby, Nigel A. Turner

This study identifies de novo lipogenesis as a mechanism of gemcitabine resistance in PDAC and shows that targeting lipid synthesis enzymes enhances treatment efficacy.

bioRxiv · Dec 18, 2024 · PreprintCancer Biology